The two are hot topics, but how do they combine in the arena of HIV? That's what two lectures at Grand Valley State University's Allendale Campus will explore on April 13. The first lecture is by ...

The conference emphasized advancements in HIV pathogenesis, persistence, and gene therapy, alongside policy and drug use intersections. Lenacapavir was found safe in adolescents, offering new insights ...

Overall, the story of HIV is one of astounding success. But to declare victory, it will be necessary to develop a vaccine. The opening session of the 31st Conference on Retroviruses and Opportunistic ...

Since then, he s shot for numerous publications in African, Spain, and Thailand. Locally, his work has appeared in the Tri-State Defender. He also happens to be HIV positive, and he ll be speaking at ...

The Lectures and Events Committee at Penn State Hazleton will host the annual Mylar Giri lecture 7 p.m., April 24, in Room 115 of the Evelyn Graham Academic Building, providing an opportunity for ...

Dr. Anthony Fauci detailed his extensive career leading the U.S. through multiple health crises in his role as the director of the National Institute of Allergy and Infectious Diseases and emphasized ...

Residents grew more knowledgeable and more comfortable with using pre-exposure prophylaxis (PrEP) drugs for prevention against HIV after training was included in their residency program. PrEP is ...

The T-20 vs. Optimized Regimen Only Study 1 (TORO 1) was a randomized, open-label, phase 3 study of enfuvirtide (T-20), a human immunodeficiency virus type 1 (HIV-1) fusion inhibitor. Patients from 48 ...